ATRC
14.2.2024 16:13:28 CET | Business Wire | Press release
Abu Dhabi’s Advanced Technology Research Council (ATRC) signed a Memorandum of Understanding (MoU) with the Ministry of Information and Telecommunications of the Republic of Serbia, and the Institute for Artificial Intelligence Research and Development of Serbia. This landmark collaboration aims to leverage the technical expertise of ATRC and its subsidiaries for integration of Artificial Intelligence (AI) into Serbia’s technological infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240214719869/en/
His Excellency Shahab Issa Abu Shahab, Director General of ATRC, Mihailo Jovanović, Minister of Information and Telecommunications of the Republic of Serbia and Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia signed a Memorandum of Understanding on the sidelines of the World Government Summit 2024. (Photo: AETOSWire)
Under the terms of the MoU, Serbia will support the adoption of the ATRC’s Falcon large language models (LLM) and explore avenues of collaboration with ATRC around Falcon-powered solutions. Furthermore, both entities will work together to encourage organizations from Serbia to join the Falcon Foundation and contribute to the success of open-source Falcon models.
The MoU was signed by His Excellency Shahab Issa Abu Shahab, Director General of ATRC, Mihailo Jovanovic, Minister of Information and Telecommunications of the Republic of Serbia, and Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia, on the sidelines of the World Governments Summit 2024.
Expressing optimism about the alliance, His Excellency Shahab Issa Abu Shahab, Director General of ATRC said: “AI is a powerful catalyst for innovation and progress. The collaboration between ATRC, the Serbian Ministry of IT, and its Institute of AI Research and Development, marks a critical milestone as we witness an increasing global interest in adopting Falcon. Our shared commitment to the Falcon open-source models ensures a dynamic and inclusive approach to advancing AI capabilities worldwide.”
For his part, Mihailo Jovanović, Minister of Information and Telecommunications of the Republic of Serbia said, “We are taking a step further and thanks to the expertise of the Advanced Technology Research Council (ATRC), we are starting to use and apply Falcon open source models for the development of AI in Serbia. This step forward will help us in further implementation of modernization projects within the Serbia 2027 Programme and strengthen the position of Serbia as a technological and digital leader in the region of Southeast Europe.”
Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia, also remarked: “We are thrilled to embark on this transformative journey with ATRC. By integrating Falcon open-source models across the board, we aim to drive breakthroughs in AI research and development. Partnerships with governments worldwide are crucial for creating an environment where innovation flourishes, ensuring that AI becomes a driving force for positive change.”
The Falcon LLMs are a family of powerful, open-source large language models developed by the Technology Innovation Institute, ATRC’s applied research arm.
The partnership marks a significant stride in exporting Falcon’s capability at a country level beyond the Middle East, laying the groundwork for global collaborative initiatives that will shape the future of technological innovation.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240214719869/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 12:00:00 CEST | Press release
Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 11:11:00 CEST | Press release
£175m for first Haleon manufacturing site in Madhya Pradesh, central IndiaFast-growing India key to Haleon reaching one billion more consumers by 2030India’s consumer health market to reach over £23bn by 20301Accelerated rural distribution to access 3 million outletsAffordable Sensodyne packs and investment to double ‘last-mile’ reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/e
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 10:56:00 CEST | Press release
Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at World ADA Diabetes & Obesity Conference Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the int
Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 10:00:00 CEST | Press release
Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'
Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 10:00:00 CEST | Press release
Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
